Despite its advantages such as safety, unnecessary pretreatment, and decontamination of waste with complex geometry, conventional ultrasonic decontamination technology has been only used to remove loose contaminants, oil and grease, not fixed contaminants due to the limitations in increasing the intensity in the high frequency range. Thus, ultrasound has been used as an auxiliary method to accelerate chemical decontamination of radioactive wastes or chemicals were added to the solution to increase the decontamination efficiency. The recently developed high-intensity focused ultrasound (HIFU) decontamination technology overcomes these limitations by combining multiple frequencies of ultrasonic waves in a specific arrangement, making it possible to remove most fixed contaminants, including radioactive micro particles less than 1 micrometer within half an hour. KEPCO NF and EnesG developed mobile HIFU decontamination equipment and successfully demonstrated the decontamination effect on various radionuclides found in nuclear power plants by treating radioactive metal waste to the level below free release criteria. The mobile HIFU decontamination equipment used in the demonstration can be operated anywhere where water is supplied, including controlled area in nuclear power plants, and is expected to be used widely for decontamination and free release of metal radioactive wastes.

High intensity focused ultrasound (HIFU) treatment of uterine myoma is a non-invasive procedure that uses high intensity, focused ultrasound to heat and destroy the tissue of uterine myoma. The history of using therapeutic ultrasound dates back to the early 20th century, and since, the technique has been continuously improved to an extent that the breadth of its clinical applications, both diagnostic and therapeutic, justify the integral role it plays in medicine today. HIFU treatment requires that ultrasound beams be focused on targeted uterine myoma. Due to significant energy dissipation at the focus, temperatures within tissues increase to more than 65℃, and destroy diseased tissue. This technology can achieve precise "ablation" of myoma tissue, and because it destroys diseased tissue non-invasively, it is also known as "Non-invasive HIFU surgery". Development of this technology significantly broadened the range of treatment options for patients suffering from uterine myoma. Furthermore, in contrast to surgery, HIFU requires only a short period of hospitalization and has a low complication rate. Today, HIFU is being used more frequently to treat adenomyosis, but its increased use has led to the reporting of more complications. Here, the authors report a case of uterine perforation after HIFU ablation for adenomyosis.